GIUGGIOLI, DILIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.649
EU - Europa 15.572
AS - Asia 11.019
SA - Sud America 1.618
AF - Africa 207
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 17
Totale 55.116
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 26.305
IT - Italia 5.888
GB - Regno Unito 4.577
CN - Cina 3.759
SG - Singapore 3.315
HK - Hong Kong 1.568
BR - Brasile 1.314
SE - Svezia 1.226
DE - Germania 889
VN - Vietnam 593
RU - Federazione Russa 567
UA - Ucraina 561
TR - Turchia 505
FR - Francia 466
FI - Finlandia 444
KR - Corea 326
ID - Indonesia 254
BG - Bulgaria 225
IN - India 225
NL - Olanda 188
CA - Canada 164
AR - Argentina 130
MX - Messico 119
JP - Giappone 108
ZA - Sudafrica 97
IE - Irlanda 87
ES - Italia 71
PL - Polonia 65
AT - Austria 56
BD - Bangladesh 54
EC - Ecuador 47
BE - Belgio 46
LT - Lituania 46
IR - Iran 38
MY - Malesia 37
IQ - Iraq 33
AE - Emirati Arabi Uniti 32
AU - Australia 29
EG - Egitto 29
RO - Romania 29
BZ - Belize 26
VE - Venezuela 25
MA - Marocco 24
PK - Pakistan 24
CZ - Repubblica Ceca 23
CH - Svizzera 22
PE - Perù 22
PY - Paraguay 22
CO - Colombia 21
SA - Arabia Saudita 19
CL - Cile 18
TN - Tunisia 15
KE - Kenya 14
EU - Europa 13
AL - Albania 12
IL - Israele 12
PH - Filippine 11
TH - Thailandia 11
UZ - Uzbekistan 11
AZ - Azerbaigian 10
JO - Giordania 10
PT - Portogallo 10
TW - Taiwan 10
BY - Bielorussia 9
HU - Ungheria 9
LV - Lettonia 9
OM - Oman 9
UY - Uruguay 9
BO - Bolivia 7
LU - Lussemburgo 7
GR - Grecia 6
KG - Kirghizistan 6
KZ - Kazakistan 6
NP - Nepal 6
AM - Armenia 5
JM - Giamaica 5
RS - Serbia 5
BA - Bosnia-Erzegovina 4
BB - Barbados 4
DO - Repubblica Dominicana 4
EE - Estonia 4
MK - Macedonia 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
SN - Senegal 4
GE - Georgia 3
GT - Guatemala 3
HN - Honduras 3
MD - Moldavia 3
MV - Maldive 3
NG - Nigeria 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BH - Bahrain 2
CR - Costa Rica 2
DK - Danimarca 2
DZ - Algeria 2
ET - Etiopia 2
HR - Croazia 2
KH - Cambogia 2
Totale 55.064
Salva come PNG Salva come JPEG
Città #
Southend 3.361
Santa Clara 2.998
Fairfield 2.598
Singapore 2.132
Ashburn 2.003
Hong Kong 1.564
Woodbridge 1.481
Hefei 1.420
Chandler 1.325
Houston 1.202
Jacksonville 944
Seattle 938
Wilmington 912
Chicago 848
Cambridge 829
Ann Arbor 740
Los Angeles 692
Nyköping 679
London 674
Dearborn 621
Beijing 499
Milan 414
Salt Lake City 396
Modena 372
Rome 369
New York 315
Izmir 297
Seoul 295
San Diego 284
Helsinki 237
Princeton 234
Sofia 221
Ho Chi Minh City 215
Jakarta 209
Bologna 191
Tampa 185
The Dalles 177
Buffalo 167
Elk Grove Village 163
Moscow 158
Eugene 157
Council Bluffs 147
Dallas 147
Shanghai 142
São Paulo 127
Hanoi 123
Bremen 120
Frankfurt am Main 113
Florence 110
Atlanta 104
Redwood City 104
Naples 102
Munich 92
Des Moines 91
Columbus 89
Palermo 88
Guangzhou 81
Lancaster 76
Sterling 76
Phoenix 75
Dublin 72
Tokyo 71
Parma 67
Kent 65
Catania 64
Bari 60
Falls Church 59
Mexico City 57
Turin 56
Miami 55
Redondo Beach 54
Detroit 53
San Jose 52
Denver 50
Norwalk 50
Warsaw 50
Genoa 49
Johannesburg 49
Montreal 47
Padova 47
Reggio Emilia 47
Verona 47
Boardman 45
Dulles 45
Ovada 45
Stockholm 41
Toronto 41
Brussels 39
Chennai 39
New Delhi 39
Nuremberg 39
Belo Horizonte 37
Delhi 36
Orem 36
Turku 36
Brooklyn 35
Cagliari 34
Kansas City 34
Manchester 34
San Francisco 34
Totale 37.433
Salva come PNG Salva come JPEG
Nome #
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 3.700
ALTERAZIONI CAPILLAROSCOPICHE IN CORSO DI DERMATOMIOSITE E SCLEROSI SISTEMICA; VERSO L’INDIVIDUAZIONE DI PATTERN SPECIFICI 861
Thyroid Involvement in Hepatitis C Virus-Infected Patients with/without Mixed Cryoglobulinemia 737
HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC) 722
Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. 402
Oxycodone in the Long-Term Treatment of Chronic Pain Related to Scleroderma Skin Ulcers. 394
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 385
Evoluzione dello CSURI (Capillaroscopic Skin Ulcer Risk Index) in pazienti affetti da sclerosi sistemica in terapia con antiendotelina-1 e prostanoidi 378
Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. 368
Systemic sclerosis progression INvestiGation (SPRING) Italian registry: Demographic and clinico-serological features of the scleroderma spectrum 353
Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature. 351
D-penicillamine in the treatment of eosinophilic fasciitis: case reports and review of the literature. 348
Effect of treatment with iloprost with or without bosentan on nailfold videocapillaroscopic alterations in patients with systemic sclerosis 342
Nailfold Videocapillaroscopy Alterations in Dermatomyositis and Systemic Sclerosis: Toward Identification of a Specific Pattern 339
Hepatitis C virus infection and type 1 and type 2 diabetes mellitus 335
Thymus alterations and systemic sclerosis 332
Radiological thymus alterations in systemic sclerosis: our experience and a review of the literature. 328
Human parvovirus B19 experimental infection in human fibroblasts and endothelial cells cultures 327
Heart involvement and systemic sclerosis 327
Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature 325
Mixed cryoglobulinemia: Demographic, clinical, and serologic features and survival in 231 patients 322
COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series 319
Scleroderma digital ulcers complicated by infection with fecal pathogens. 317
CXCL10 (α) and CCL2 (β) chemokines in systemic sclerosis - A longitudinal study 317
Incidence of thyroid disorders in systemic sclerosis: results from a longitudinal follow-up. 314
Current treatment of hepatitis C-associated rheumatic diseases. 306
Treatment of severe scleroderma skin ulcers with recombinant human erythropoietin 303
Efficacia di terapia con immunoassorbimento con proteina A dello stafilococco e talidomide in un caso di dermatomiosite refrattaria. 300
Correlation of articular involvement, skin disfigurement, and unemployment with depressive symptoms in patients with systemic sclerosis: a hospital sample 296
L-Arginine in pregnant scleroderma patients 296
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection. 294
Aortic pulse wave velocity measurement in systemic sclerosis patients. 291
Cardio-pulmonary disease management in patients with systemic sclerosis: cardio-rheumatology clinic and patient care standardisation proposal 289
Thyroid involvement in patients with HCV-related mixed cryoglobulinaemia 288
Elevated Troponin Serum Levels in Adult Onset Still's Disease 286
Established coronary artery disease in systemic sclerosis compared to type 2 diabetic female patients: a cross-sectional study 282
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 279
Recombinant human erythropoietin stimulates vasculogenesis and wound healing in a patient with systemic sclerosis complicated by severe skin ulcers. 278
Cardiac involvement in systemic sclerosis: identification of high-risk patient profiles in different patterns of clinical presentation 276
Targeting chemokine (C-X-C motif) receptor 3 in thyroid autoimmunity 276
HCV and cryoglobulinemic vasculitis. 275
Platelet gel in the treatment of severe scleroderma skin ulcers. 275
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature 274
Breast cancer in systemic sclerosis: Results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature 274
Chemokines in the pathogenesis and as therapeutical markers and targets of HCV chronic infection, and HCV extrahepatic manifestations 274
Successful treatment with leflunomide of arthritis in systemic sclerosis patients 272
Cryoglobulinemic vasculitis and skin ulcers. Our therapeutic strategy and review of the literature 270
Parvoviral infection of endothelial cells and stromal fibroblasts: a possible pathogenetic role in scleroderma 269
Unusual association between Budd–Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: a case report and review of the literature 265
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 261
SAT0633-HPR Articular Involvement of the Scleroderma Hand: An Assessment Protocol for Planning Occupational Therapy Strategies 256
Haematological Malignancies in Systemic Sclerosis Patients: Case Reports and Review of the World Literature 255
Antiendothelial cell antibodies induce apoptosis of bone marrow endothelial progenitors in systemic sclerosis 254
Application of Agents Against Interferon-Gamma-Dependent Chemokines in Immunotherapy 253
Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications 253
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 252
Autoimmune and neoplastic thyroid diseases associated with hepatitis C chronic infection 251
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 251
Induction of CXCL10 secretion by interferon-γ and tumour necrosis factor-α and its inhibition by peroxisome proliferator-activated receptor-γ agonists in cultured scleroderma fibroblasts. 251
Cardiovascular risk and prostanoids in systemic sclerosis 250
Polymyositis following Pandemic Influenza A (H1N1) and 2009-10 Seasonal Trivalent Vaccines 249
Prediction risk chart for scleroderma digital ulcers: A composite predictive model based on capillaroscopic, demographic and clinico-serological parameters 245
The link between pain patient and analgesic medication is greater in migraine than in rheumatic disease patients 244
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature 244
Associations between Systemic Sclerosis and Thyroid Diseases 242
Amlodipine in the treatment of Raynaud's phenomenon 241
Brief report: successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: an Italian multicenter study 241
Management of cardiopulmonary disease in patients with systemic sclerosis: cardiorheumatology clinic and patient care standardization proposal 239
Capillaroscopic Skin Ulcers Risk Index (CSURI) calculated with different videocapillaroscopy devices: how its predictive values change 238
Autonomic dysfunction in systemic sclerosis: time and frequency domain 24 hour heart rate variability analysis 235
CORRELATION OF A QUANTITATIVE VIDEOCAPILLAROSCOPIC SCORE WITH THE DEVELOPMENT OF DIGITAL SKIN ULCERS IN SCLERODERMA PATIENTS 231
Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature 231
Autologous skin grafting in the treatment of severe scleroderma cutaneous ulcers: a case report 230
Correlation of a quantitative videocapillaroscopic score with the development of digital skin ulcers in scleroderma patients 230
Ultrasonography involvement of carotid, upper and lower limb arteries in a large cohort of systemic sclerosis patients 229
HCV-related rheumatic manifestations and therapeutic strategies 227
Long-term treatment with rituximab in interstitial lung disease related to systemic sclerosis: our clinical experience 225
Validation study of predictive value of capillaroscopic skin ulcer risk index (CSURI) in scleroderma patients treated with bosentan 225
HHV-6A infection and systemic sclerosis: Clues of a possible association 223
Systemic sclerosis following human cytomegalovirus infection 221
Renal Manifestations of Hepatitis C Virus 220
Micro and nanoparticles as possible pathogenetic co-factors in mixed cryoglobulinemia 220
Use of Neem oil and Hypericum perforatum for treatment of calcinosis-related skin ulcers in systemic sclerosis 217
CAPILLAROSCOPIC SKIN ULCER RISK INDEX (CSURI) IN SYSTEMIC SCLEROSIS: RESULTS FROM AN ITALIAN MULTICENTER VALIDATION STUDY 213
The safety of iloprost in systemic sclerosis in a real-life experience 213
The treatment of skin ulcers in systemic sclerosis: use of granulocyte-colony stimulating factor (G-CSF) in 26 patients 212
Measuring microangiopathy abnormalities in systemic sclerosis patients: the role of capillaroscopy-based scoring models 212
Clinical and Pathological Features of Breast Cancer in Systemic Sclerosis: Results from the Sclero-Breast Study 212
Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2 211
Novel Therapies for Thyroid Autoimmune Diseases 210
Treatment of HCV-related mixed cryoglobulinemia 210
CLINICAL AND PATHOLOGICAL FEATURES OF BREAST CANCER IN PATIENTS WITH SYSTEMIC SCLEROSIS: PRELIMINARY DATA FROM THE SCLERO-BREAST STUDY 210
UNCLASSIFIABLE INTERSTITIAL LUNG DISEASE OR UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE? A CHALLENGING DIFFERENTIAL DIAGNOSIS 207
Right ventricular overload and cardiovascular neuroendocrine derangement in systemic sclerosis 205
Phantom Limb Pain in Patients with Severe Cryoglobulinemic Vasculitis: Usefulness of Long-Term Pregabalin Treatment 205
Autologous Fat Grafting for the Oral and Digital Complications of Systemic Sclerosis: Results of a Prospective Study 205
[The alpha chemokine "Interferon gamma-induced protein 10" (IP-10) in Graves' disease and Graves'ophthalmopathy] 204
Scleroderma Digital Ulcers Complicated by Infection with Fecal Pathogens. 203
Advanced oxidation protein products in serum of patients with systemic sclerosis: a possible indicator of clinical evolution 201
Hepatitis C virus syndrome: A constellation of organ- and non-organ specific autoimmune disorders, B-cell non-Hodgkin's lymphoma, and cancer 200
Totale 31.698
Salva come PNG Salva come JPEG
Categoria #
all - tutte 227.130
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 227.130
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.974 0 0 0 0 0 492 1.048 796 315 526 494 303
2021/20224.403 221 363 353 386 166 334 194 269 463 381 741 532
2022/20235.029 579 419 282 369 592 677 260 478 651 153 324 245
2023/20244.331 184 282 254 492 753 327 363 472 109 237 349 509
2024/202512.041 472 216 243 827 2.233 1.779 830 635 1.329 769 1.254 1.454
2025/202612.713 1.493 902 1.916 3.447 4.673 282 0 0 0 0 0 0
Totale 55.675